(DYN) Dyne Therapeutics - Performance -75.5% in 12m
DYN performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-54.42%
#79 in Peer-Group
Rel. Strength
4.19%
#7116 in Stock-Universe
Total Return 12m
-75.54%
#167 in Peer-Group
Total Return 5y
-63.68%
#73 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 47.04 USD |
| 52 Week Low | 6.81 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 15.34 |
| Buy/Sell Signal +-5 | -0.98 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: DYN (-75.5%) vs XBI (-10.7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.32% | 68% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-10.6% | -8.81% | 144% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
0.71% | -3.57% | 32.5% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.36% | 31.7% | -6.18% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
2.76% | -8.64% | 0.27% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.5% | 65.3% | -5.65% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
-0.49% | 55.9% | -10.1% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
3.44% | 35.3% | 14.7% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: DYN vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for DYN
| Total Return (including Dividends) | DYN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -31.65% | 2.27% | 4.52% |
| 3 Months | -5.96% | 6.30% | 10.43% |
| 12 Months | -75.54% | -10.68% | 14.67% |
| 5 Years | -63.68% | -26.13% | 109.23% |
| Trend Score (consistency of price movement) | DYN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -77% | 5.5% | 79.1% |
| 3 Months | 49.6% | 74.3% | 94.2% |
| 12 Months | -93% | -84.7% | 44.4% |
| 5 Years | 6.8% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th3.50 | -33.17% | -34.61% |
| 3 Month | %th38.50 | -11.54% | -14.84% |
| 12 Month | %th17.00 | -72.62% | -78.67% |
| 5 Years | %th64.00 | -49.94% | -81.61% |
FAQs
Does Dyne Therapeutics (DYN) outperform the market?
No,
over the last 12 months DYN made -75.54%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.68%.
Over the last 3 months DYN made -5.96%, while XBI made 6.30%.
Performance Comparison DYN vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
DYN vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -20.1% | -36.2% | -72.2% | -90% |
| US NASDAQ 100 | QQQ | -19.7% | -36.3% | -73.4% | -90% |
| German DAX 40 | DAX | -18.4% | -30.6% | -83.7% | -104% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -19.2% | -35.8% | -73.1% | -93% |
| Hongkong Hang Seng | HSI | -18.4% | -37.7% | -89.9% | -111% |
| India NIFTY 50 | INDA | -20.2% | -34% | -70.5% | -76% |
| Brasil Bovespa | EWZ | -21.2% | -39.2% | -95.1% | -89% |
DYN vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -20.7% | -37.7% | -77.3% | -103% |
| Consumer Discretionary | XLY | -19.6% | -33.7% | -65% | -96% |
| Consumer Staples | XLP | -19.1% | -31.2% | -71.8% | -86% |
| Energy | XLE | -19% | -36% | -66.1% | -72% |
| Financial | XLF | -20.4% | -35.3% | -75.9% | -105% |
| Health Care | XLV | -20.5% | -35.2% | -66.1% | -71% |
| Industrial | XLI | -20.4% | -35.7% | -79.3% | -100% |
| Materials | XLB | -21.1% | -35.9% | -75.2% | -81% |
| Real Estate | XLRE | -17% | -32.3% | -71% | -89% |
| Technology | XLK | -19.9% | -39.6% | -74.5% | -86% |
| Utilities | XLU | -18.8% | -32.1% | -74.9% | -100% |
| Aerospace & Defense | XAR | -20.8% | -38.9% | -90.6% | -125% |
| Biotech | XBI | -17.5% | -33.9% | -56.7% | -65% |
| Homebuilder | XHB | -22.7% | -42.1% | -65.6% | -81% |
| Retail | XRT | -21.1% | -36.1% | -66.5% | -85% |
DYN vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -19.6% | -38.0% | -62.0% | -66% |
| Natural Gas | UNG | -11.3% | -21.2% | -54.7% | -67% |
| Gold | GLD | -18.8% | -30.3% | -91.2% | -118% |
| Silver | SLV | -18.7% | -35.3% | -87.5% | -97% |
| Copper | CPER | -21.2% | -35.6% | -90.6% | -91% |
DYN vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -19.2% | -35.2% | -68.4% | -77% |
| iShares High Yield Corp. Bond | HYG | -18.3% | -32.9% | -70.1% | -86% |